Altimmune Inc.
ALT:NASDAQ
Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for liver disease and immune modulating therapies. Our diverse pipeline includes next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell™), conjugated immunostimulants for the treatment of cancer (ALT-702) and intranasal vaccines (NasoVAX™ and NasoShield™).
Streetwise Company Fact Sheet2025/10/28 1:23:21
(ALT:NASDAQ)
Analyst coverage
| H.C. Wainwright & Co. — Patrick Trucchio |
Streetwise Reports Articles
| 10/15/2025 - View Article |
© 2025 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
